Find out about the latest developments and changes happening at iVigee here.
Audio Recap, Click Here. Gambia updated its Guideline for Clinical Trials in Humans, effective February 26. This change impacts multiple regulatory areas including aggregate safety reports, clinical trials, and post-marketing ICSR reporting. iViReg users received the validated alert on March 3, with full updates reflected in the Gambia Country Profile by March 10.
Sign up to receive free alerts just like these!
Whatever your pharmacovigilance requirements, our world-leading technology platforms and globally experienced operational teams can provide the solution.